Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 11,259 | 6,201 | 5,412 | 10,165 | 5,036 |
| Operating Income | -11,259 | -6,201 | -5,412 | -10,165 | -5,036 |
| Other Income | 287 | 330 | 20 | -174 | -27 |
| Pre-tax Income | -10,972 | -5,871 | -5,392 | -10,339 | -5,063 |
| Net Income Continuous | -10,972 | -5,684 | -5,392 | -10,339 | -5,063 |
| Net Income | $-10,972 | $-5,684 | $-5,392 | $-10,339 | $-5,063 |
| EPS Basic Total Ops | -0.29 | 0.55 | -0.17 | -1.05 | -0.52 |
| EPS Basic Continuous Ops | -0.29 | 0.53 | -0.17 | -1.03 | -0.51 |
| EPS Diluted Total Ops | -0.29 | 0.55 | -0.17 | -1.05 | -0.52 |
| EPS Diluted Continuous Ops | -0.29 | 0.53 | -0.17 | -1.03 | -0.51 |
| EBITDA(a) | $-11,259 | $-6,201 | $-5,412 | $-10,165 | $-5,036 |